Molecular Templates' Series B Round

Molecular Templates raised a round of funding on April 15, 2011. Investors include Sante Ventures.

Molecular Templates is a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics with advantages over existing Antibody Drug Conjugates (ADC…

Articles about Molecular Templates' Series B Round: